SCHEMBL4623759

SCHEMBL4623759

CNC1CCN(Cc2cnc[nH]2)CC1

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 12/20 0.51
SIGMAR1 Q99720 1/20 0.51
HRH4 Q9H3N8 2/20 0.47
MPG P29372 1/20 0.46
CHRM3 P20309 1/20 0.46
KAT2B Q92831 1/20 0.45
CXCR4 P61073 1/20 0.44
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
DRD2 P14416 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14375261 0.84 HRH3 (0.56) HRH3SIGMAR1HRH4MPGCHRM3
SCHEMBL13512586 0.80 HRH3 (0.64) HRH3HRH4MPGCHRM3CXCR4
SCHEMBL14197766 0.77 HRH3 (0.52) HRH3SIGMAR1HRH4MPGCHRM3
SCHEMBL4623756 0.77 HRH3 (0.57) HRH3HRH4MPGCHRM3CXCR4
SCHEMBL2750851 0.77 HRH3 (0.62) HRH3HRH4MPGDRD2
Hydrochloric Acid SCHEMBL4880416 0.76 HRH3 (0.56) HRH3HRH4MPGCHRM3CXCR4
SCHEMBL27864314 0.76 HRH3 (0.58) HRH3HRH4MPGDRD2
SCHEMBL31010330 0.75 HRH3 (0.63) HRH3HRH4MPGDRD2
SCHEMBL18502880 0.75 CYP11B2 (0.44) HRH4CXCR4DRD2
SCHEMBL4111392 0.75 SIGMAR1 (0.53) HRH3SIGMAR1MPGCHRM3CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904479-A2 NOVEL 2,4-DIANILINOPYRIMIDINE DERIVATIVES, THE PREPARATION THEREOF, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND, IN PARTICULAR, AS IKK INHIBITORS Sanofi-Aventis (FR) 2008-04-02 EP disclosed
WO-2007006926-A2 NOVEL 2,4-DIANILINOPYRIMIDINE DERIVATIVES, THE PREPARATION THEREOF, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND, IN PARTICULAR, AS IKK INHIBITORS SANOFI-AVENTIS (FR) 2007-01-18 WO disclosed